Wasopharma SRL
Wasopharma reported total assets of 11,298 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026).
The score of Wasopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wasopharma's annual accounts
| 2025 | |
|---|---|
| Net result | 2,694 € |
| Equity | 3,861 € |
| Cash | 5,738 € |
| EBITDA | 3,480 € |
| Total assets | 11,298 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
Wasopharma's financial analysis
- Solvency34.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wasopharma
Wasopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1029.094.378
- VAT number
- BE1029094378
- Peppol
- Registered · 0208:1029094378 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Oct 2025
- Registered office
- 1400 Nivelles
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Wasopharma (SRL) has been based in Nivelles since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,694 € and equity of 3,861 €; its revenue is not published. Its solvency stands at 34.2%, below the median of its sector (41.5%).
Companies similar to Wasopharma
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Pharmawings Retail sale of pharmaceutical products Pittem · balance sheet 7,404 €
- Camille Loward Retail sale of pharmaceutical products Beersel · balance sheet 18,302 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Grace Partner Retail sale of pharmaceutical products Quaregnon · balance sheet 19,066 €
- Quantum Satis Retail sale of pharmaceutical products Zele · balance sheet 34,289 €
- NN Phar Retail sale of pharmaceutical products Éghezée · balance sheet 16,773 €
- Notha Retail sale of pharmaceutical products Bonheiden · balance sheet 18,492 €
Frequently asked questions about Wasopharma
What is the revenue of Wasopharma?
Wasopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wasopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1029094378 for Wasopharma, if the company is VAT-registered. Its company number (CBE) is 1029.094.378.
Where is the registered office of Wasopharma?
According to the CBE register, the registered office of Wasopharma is in 1400 Nivelles.
What is the equity of Wasopharma?
At the close of the 2025 financial year, the equity of Wasopharma amounts to 3,861 €, a solvency of 34.2% of total assets.
Who manages Wasopharma?
The register lists 1 active mandates at Wasopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Wasopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →